SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001437749-23-005797
Filing Date
2023-03-08
Accepted
2023-03-08 16:05:30
Documents
16
Period of Report
2023-03-03
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ctdh20230308_8k.htm   iXBRL 8-K 27836
2 EXHIBIT 3.1 ex_485545.htm EX-3.1 1891
7 image01.jpg GRAPHIC 242966
8 image02.jpg GRAPHIC 180286
  Complete submission text file 0001437749-23-005797.txt   765306

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA ctdh-20230303.xsd EX-101.SCH 4036
4 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ctdh-20230303_def.xml EX-101.DEF 13892
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE ctdh-20230303_lab.xml EX-101.LAB 18207
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ctdh-20230303_pre.xml EX-101.PRE 13914
10 EXTRACTED XBRL INSTANCE DOCUMENT ctdh20230308_8k_htm.xml XML 4380
Mailing Address PO BOX 1180 ALACHUA FL 32616-1180
Business Address 6714 NW 16TH STREET, SUITE B GAINESVILLE FL 32653 386-418-8060
Cyclo Therapeutics, Inc. (Filer) CIK: 0000922247 (see all company filings)

IRS No.: 593029743 | State of Incorp.: FL | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39780 | Film No.: 23716139
SIC: 2836 Biological Products, (No Diagnostic Substances)